Seeing Is Believing
SLN is currently covered by 1 analysts
Silence Therapeutics PLC's activity chart (see below) currently has 45 price targets and 62 ratings on display. The stock rating distribution of SLN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 38.21% with an average time for these price targets to be met of 147.4 days.
Highest price target for SLN is $7, Lowest price target is $5.
Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 13-Mar-2026. First documented stock forecast 24-Aug-2020.
Currently out of the existing stock ratings of SLN, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Aug-2020
4 months 23 days ago
(13-Mar-2026)
1/13 (7.69%)
$70.15 (1446.39%)
77
Buy Since 31-Mar-2022
1 years 1 months 23 days ago
(13-Jun-2025)
2/6 (33.33%)
$39.31 (250.54%)
277
Buy Since 08-May-2023
$25
$18.9 (309.84%)
1 years 2 months 27 days ago
(09-May-2025)
6/12 (50%)
$21.3 (575.68%)
223
Sell Since 10-Feb-2025
$3
$-3.1 (-50.82%)
1 years 2 months 27 days ago
(09-May-2025)
1/2 (50%)
$-0.7 (-18.92%)
133
Buy Since 18-Nov-2020
$15
$9.27 (161.78%)
$32
2 years 8 months 21 days ago
(15-Nov-2023)
1/2 (50%)
$5.58 (59.24%)
27
What is SLN (Silence Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on SLN (Silence Therapeutics PLC) with a proven track record?
Which analyst has the current lower performing score on SLN (Silence Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most bullish on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most reserved on SLN (Silence Therapeutics PLC)?